| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.45 | 0.1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |